[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003242538A1 - Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug - Google Patents

Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug

Info

Publication number
AU2003242538A1
AU2003242538A1 AU2003242538A AU2003242538A AU2003242538A1 AU 2003242538 A1 AU2003242538 A1 AU 2003242538A1 AU 2003242538 A AU2003242538 A AU 2003242538A AU 2003242538 A AU2003242538 A AU 2003242538A AU 2003242538 A1 AU2003242538 A1 AU 2003242538A1
Authority
AU
Australia
Prior art keywords
oxo
drug
preparation
pyrrolidone derivatives
pyrrolidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003242538A
Inventor
Yves Lamberty
Roy Massingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of AU2003242538A1 publication Critical patent/AU2003242538A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003242538A 2002-05-14 2003-05-13 Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug Abandoned AU2003242538A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02010739.7 2002-05-14
EP02010739 2002-05-14
PCT/EP2003/004982 WO2003094913A1 (en) 2002-05-14 2003-05-13 Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug

Publications (1)

Publication Number Publication Date
AU2003242538A1 true AU2003242538A1 (en) 2003-11-11

Family

ID=29414682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242538A Abandoned AU2003242538A1 (en) 2002-05-14 2003-05-13 Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug

Country Status (2)

Country Link
AU (1) AU2003242538A1 (en)
WO (1) WO2003094913A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1909764T3 (en) * 2005-07-26 2014-12-15 Ucb Pharma Sa Pharmaceutical compositions comprising levetiracetam and process for their preparation
BRPI0615830A2 (en) * 2005-09-15 2012-12-18 Ucb Pharma Sa compound, processes for the preparation of 2-oxopyrrolidin-1-yl derivatives, for the preparation of substantially diastereoisomerically pure compounds, for the preparation of brivaracetam and for the preparation of seletracetam, and the use of 4-substituted-pyrrolidin -2-ounces
EA015267B1 (en) 2006-06-08 2011-06-30 Юсб Фарма, С.А. Co-crystals of pyrrolidinones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
WO2001039779A1 (en) * 1999-12-01 2001-06-07 Ucb, S.A. A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses

Also Published As

Publication number Publication date
WO2003094913A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AU2003281752A1 (en) Medicament dispenser
AU2003254590A1 (en) Medicament dispenser
AU2003246734A1 (en) Medicament dispenser
AU2003246722A1 (en) Medicament dispenser
AU2003250166A1 (en) Medicament dispenser
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003275266A1 (en) Therapeutic compounds based on pyrazolopyridine derivatives
IL213809A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
AU2003229738A1 (en) Medicament dispenser
AU2003226189A1 (en) Oral administration of epothilones
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003213185A1 (en) Arylsulfone derivatives
AU2002950657A0 (en) Derivatives of monosaccharides for drug discovery
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU2003233083A1 (en) Medicament dispenser
AU2003281268A1 (en) Cephalosporin preparation for oral use
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
AU2003281698A1 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
AU2003208621A1 (en) A pharmaceutical composition
AU2003232785A1 (en) Novel anthracene derivatives and the use thereof as a medicament
AU2002253441A1 (en) Medicaments containing glycerophosphoinositol-4-phosphate derivatives
AU2003242538A1 (en) Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
AU2003264443A1 (en) Preparation for external use
AU2002335304A1 (en) The use of berberine as insulin sensitizer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 603 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME UCB, S.A., APPLICATION NO.2003242538, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003